Last reviewed · How we verify
KM-001 cream 1% 12 weeks treatment.
KM-001 cream 1% 12 weeks treatment. is a Small molecule drug developed by Kamari Pharma Ltd. It is currently in Phase 1 development. Also known as: Experimental drug administration-cohort 1.
At a glance
| Generic name | KM-001 cream 1% 12 weeks treatment. |
|---|---|
| Also known as | Experimental drug administration-cohort 1 |
| Sponsor | Kamari Pharma Ltd |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Assessment of KM-001 - Safety, Tolerability, and Efficacy in Patients With PPPK1 or PC (PHASE1)
- Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases (PHASE1)
- KM-001 Cream for Treatment of Pruritus in Adult Patients With Lichen Simplex Chronicus (LSC) (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- KM-001 cream 1% 12 weeks treatment. CI brief — competitive landscape report
- KM-001 cream 1% 12 weeks treatment. updates RSS · CI watch RSS
- Kamari Pharma Ltd portfolio CI
Frequently asked questions about KM-001 cream 1% 12 weeks treatment.
What is KM-001 cream 1% 12 weeks treatment.?
KM-001 cream 1% 12 weeks treatment. is a Small molecule drug developed by Kamari Pharma Ltd.
Who makes KM-001 cream 1% 12 weeks treatment.?
KM-001 cream 1% 12 weeks treatment. is developed by Kamari Pharma Ltd (see full Kamari Pharma Ltd pipeline at /company/kamari-pharma-ltd).
Is KM-001 cream 1% 12 weeks treatment. also known as anything else?
KM-001 cream 1% 12 weeks treatment. is also known as Experimental drug administration-cohort 1.
What development phase is KM-001 cream 1% 12 weeks treatment. in?
KM-001 cream 1% 12 weeks treatment. is in Phase 1.
Related
- Manufacturer: Kamari Pharma Ltd — full pipeline
- Also known as: Experimental drug administration-cohort 1
- Compare: KM-001 cream 1% 12 weeks treatment. vs similar drugs
- Pricing: KM-001 cream 1% 12 weeks treatment. cost, discount & access